Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Repligen Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
RGEN
Nasdaq
2836
https://www.repligen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Repligen Corp
Here’s Why Baron Discovery Fund Sold Repligen Corporation (RGEN)
- May 15th, 2024 1:53 pm
We Discuss Why Repligen Corporation's (NASDAQ:RGEN) CEO Compensation May Be Closely Reviewed
- May 10th, 2024 10:33 am
Repligen Corporation to Present at Upcoming May Investor Conferences
- May 7th, 2024 11:30 am
Repligen First Quarter 2024 Earnings: EPS Misses Expectations
- May 3rd, 2024 1:35 pm
Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
- May 2nd, 2024 3:31 pm
Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates
- May 2nd, 2024 3:23 pm
Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Shifts and ...
- May 2nd, 2024 7:06 am
Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment with Analyst Projections
- May 1st, 2024 1:11 pm
Repligen (RGEN) Misses Q1 Earnings Estimates
- May 1st, 2024 12:50 pm
Repligen Reports First Quarter 2024 Financial Results
- May 1st, 2024 11:30 am
Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
- Apr 23rd, 2024 3:43 pm
Repligen to Report First Quarter 2024 Financial Results
- Apr 17th, 2024 11:30 am
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
- Apr 12th, 2024 2:07 pm
Repligen Appoints Maggie A. Pax to Board of Directors
- Mar 19th, 2024 11:30 am
Are Repligen Corporation's (NASDAQ:RGEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
- Mar 18th, 2024 2:30 pm
Repligen Corp CEO Anthony Hunt Sells 16,707 Shares
- Mar 12th, 2024 5:18 am
PBYI vs. RGEN: Which Stock Is the Better Value Option?
- Mar 4th, 2024 4:40 pm
Repligen Corp COO James Bylund Sells 4,373 Shares
- Feb 27th, 2024 7:02 am
Estimating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)
- Feb 26th, 2024 11:25 am
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight
- Feb 24th, 2024 5:03 am
Scroll